Organogenesis Holdings Analyst Price Targets - Benzinga

Organogenesis Holdings Inc

ORGONASDAQ

Trade with Public

Trade with Public

$1.63

-0.09-5.23%

At close: Sep 1, 5:00 PM EST

$1.63

N/A

After Hours: 5:48 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Organogenesis Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Organogenesis Holdings (ORGO).

Price Target Range — 9 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$6Upside to Avg. PT+268.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Truist Securities	Ravi Misra	PT Cut	Hold	$3→$2
May 28, 2026	Truist Securities	Ravi Misra	Initiate	Hold	$3
Mar 26, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$8
Feb 27, 2026	BTIG	Ryan Zimmerman	PT Cut	Buy	$9→$8
Dec 26, 2025	BTIG	Ryan Zimmerman	Maintained	Buy	$9
Dec 15, 2025	BTIG	Ryan Zimmerman	Maintained	Buy	$9
Nov 20, 2025	BTIG	Ryan Zimmerman	PT Raise	Buy	$7→$9
Sep 26, 2025	BTIG	Ryan Zimmerman	Maintained	Buy	$7
Aug 8, 2025	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$7→$9
Jul 15, 2025	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$7
Mar 5, 2025	Morgan Stanley	Drew Ranieri	PT Raise	Equal-Weight	$4→$6
Jun 28, 2024	Lake Street	Brooks O'Neil	Initiate	Buy	$5
Mar 1, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$5
Feb 7, 2024	Cantor Fitzgerald	Ross Osborn	Initiate	Overweight	$5
Dec 27, 2023	BTIG	Ryan Zimmerman	PT Raise	Buy	$4→$6
Nov 14, 2023	Morgan Stanley	Drew Ranieri	PT Raise	Equal-Weight	$3→$4

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Organogenesis Holdings, Lowers Price Target to $2

Truist Securities analyst Ravi Misra maintains Organogenesis Holdings (NASDAQ:ORGO) with a Hold and lowers the price target from $3 to $2.

Benzinga Newsdesk

This Suncrete Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Top analysts change outlook on top names. Check out analyst ratings page for all changes. RMIX, ABSI, and ORGO get coverage with targets.

Avi Kapoor

PRO
Truist Securities Initiates Coverage On Organogenesis Holdings with Hold Rating, Announces Price Target of $3

Truist Securities analyst Ravi Misra initiates coverage on Organogenesis Holdings (NASDAQ:ORGO) with a Hold rating and announces Price Target of $3.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Organogenesis Holdings, Maintains $8 Price Target

BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Organogenesis Holdings, Lowers Price Target to $8

BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and lowers the price target from $9 to $8.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Organogenesis Holdings, Maintains $9 Price Target

BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $9 price target.

Benzinga Newsdesk